Top

Archives of Gynecology and Obstetrics

Published in:

Open Access 01-03-2012 | Maternal-Fetal Medicine

Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome

Author: Shahla Alalaf

Published in: Archives of Gynecology and Obstetrics | Issue 3/2012

Abstract

Study objective

To compare the live birth rate of women presented with recurrent miscarriages in the first trimester due to antiphospholipid antibody syndrome (APS), randomized to either low molecular weight heparin (Bemiparin) or low dose aspirin (LDA) and to determine the maternal and fetal adverse effects in both treatment groups.

Patients and methods

A clinical comparative study was conducted in Maternity teaching Hospital, Erbil city, north of Iraq, Kurdistan region from 15th of September 2007 to the 1st of August 2010 on 141 women presented with 2 or more consecutive miscarriages due to APS, the women randomized to receive either prophylactic dose of Bemiparin with the diagnosis of pregnancy or LDA started preconceptioally and until 36 weeks gestation. The primary outcome was live birth rate in both treatment groups, the secondary outcomes were maternal and fetal complications in both trial groups.

Result

There was no statistically significant difference between the two groups regarding demographic characters (age groups, parity, gestational age and history of previous abortion), and mode of delivery of the viable newborns.

There was a statistically significant difference between the two treatment groups regarding live birth rate. The proportions of women who gave birth to a live infant were 72.13% in the LDA group and 86.25% in the Hibor group, the mean difference between the live birth rate in both group was 0.141 (95% Confidence interval of the difference, 0.08, 0.274). The average birth weight for women received LDA was significantly lower than women who received Bemiparin.

Conclusion

The use of the new second generation LMWH (Bemiparin) in comparison to LDA during pregnancy for prevention of recurrent miscarriage in women with APS is a safe, reliable method with a high live birth rate and no maternal and fetal complications.

Bricker L, Farquharson G (2000) Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod 17:1345–1350CrossRef

Carson A, Branch W (2001) Management of recurrent early pregnancy loss, Compendium selected publications. American College of Obstetricians and Gynecologists, Washington, DC, pp 372–383

Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601–611PubMedCrossRef

Clifford K, Rai R, Waston H, Regan L (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 9:1328–1332PubMed

Clark A (1999) Critically examining the immunologic causes of recurrent miscarriage. MedGenMed 1(3). Formerly published in Medscape Women’s Health eJournal 4(3); 1999. Available at http://www.medscape.com/veiwarticle/405322

Jauniaux E, Farquharson G, Christiansen B, Exalto N (2006) Evidence-based guidelines for the investigation and medical treatment for recurrent miscarriage. Hum Reprod 21(9):2216–2222. Advance Access originally published online on May 17, 2006. Human Reproduction

Gautam A, Swati A (2003) Low molecular weight heparin in immunological recurrent abortion-the incredible cure. J Assist Reprod Genet 20:2

John H (2003) Antiphospholipid syndrome: an overview. Can Med Assoc J 168(13):1675–1682

Abaci A, Bober E, Yesikaya E, Bidec A, Cinaz P, Buyukgebiz A (2010) Prevalence of anticardiolipin antibodies in type 1 diabetes and autoimmune thyroiditis. Pol Arch Med Wew 120(3):71–75

10.

De Wolf F, Carreras O, Moerman P, Vermylen J, Van A, Renaer M (1982) Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 142(7):829–834PubMed

11.

Walport J (1989) Pregnancy and antibodies to phospholipids. Ann Rheum Dis 48:795–797PubMedCrossRef

12.

Mehdi A, Uthman I, Khamashta M (2010) Treatment of antiphospholipid antibody Syndrome. Int J Clin Rheumatol 5(2):241–254CrossRef

13.

Out J, Kooijman D, Bruinse W, Derksen H (1999) Histopathological findings in placentae from patients with intra uterine fetal death and anti-phospholipids antibodies. Eur J Obstet Gynecol Reprod Biol 41:179–186CrossRef

14.

Dawes J, Bara L, Billaud E, Samma M (1986) Relationship between biological activity and concentration of a low molecular weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis 16(116):122

15.

Dulitzki M, Pauzner R, Langevitz P, Many A, Schiff E (1996) Low molecular weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol 87:380–383PubMedCrossRef

16.

Asherson A, Cervera R, de Groot G et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12(7):530–534PubMedCrossRef

17.

Kutteh H (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol 174:1584–1589PubMedCrossRef

18.

Carla A, Karen A, Christine A, Mark R, Jeff S et al (2009) Low molecular weight heparin and aspirin loss: result from the randomized, controlled HepASA trail. J Rheumatol. doi:10.3899/jrheum.080763. Published online before print February 4

19.

Triolo G, Ferrante A, Ciccia F, Accardo-Palum A, Perino A et al (2003) Randomize study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48(3):728–731PubMedCrossRef

20.

Royal College of Obstetrician and Gynaecologists (2003) The investigation and treatment of recurrent miscarriage [internet], Guideline No 17. London: RCOG Press, 2003 May [cited 2009 Feb 8]. 13 p

21.

Mohamed M, Abdou O, Assem M, Mustafa M, Soghier M (2002) Anticardiolipin antibodies in children with insulin dependent diabetes mellitus. Metabolism. 51:1148–1152PubMedCrossRef

22.

Stef K, Mariette G, Joris M, Van P, Barbara H et al (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 362:1586–1596CrossRef

Title: Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome
Author: Shahla Alalaf
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 3/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-2055-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome

Abstract

Study objective

Patients and methods

Result

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Study objective

Patients and methods

Result

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2012

Role of serum interleukin-6 in comparing surgical stress after laparoscopic-assisted vaginal hysterectomy and non-descent vaginal hysterectomy for large uteri

Endometrial/uterine corporeal volume ratio (EV/UCV) as predictor of malignancy in women with postmenopausal bleeding

Biomechanics of the female pelvic floor: a prospective trail of the alteration of force–displacement-vectors in parous and nulliparous women

Pregnancy after bariatric surgery: a current view of maternal, obstetrical and perinatal challenges

Hormone replacement therapy: relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women

Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome